(Q24250225)

https://api.crossref.org/works/10.1002%2F14651858.CD003045

No Effect of Oral Testosterone Treatment on Sexual Dysfunction in Alcoholic Cirrhotic Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

A consumer's guide to subgroup analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Testosterone treatment of men with alcoholic cirrhosis: A double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: A multicenter sequential trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Practical aspects in data monitoring: a brief review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Augmented release of hepatic triglycerides with anabolic steroids in patients with fatty liver

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Budd-Chiari syndrome associated with oral contraceptive steroids. Review of treatment of 47 cases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

PROTEIN METABOLISM, EXCRETION, AND DETOXICATION FUNCTIONS OF THE LIVER AFTER LONG-TERM TREATMENT OF LIVER CIRRHOSIS WITH AN ANABOLIC SUBSTANCE

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Serum testosterone concentrations in men with alcoholic cirrhosis: Background for variation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Anabolic/androgenic steroid abuse and thrombosis: is there a connection?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Subgroup analysis and other (mis)uses of baseline data in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Prednisolone and testosterone propionate in cirrhosis of the liver. A controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Alcoholic liver disease: new insights in pathogenesis lead to new treatments

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Liver haemodynamics and function in alcoholic cirrhosis. Relation to testosterone treatment and ethanol consumption.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Attributable risk for symptomatic liver cirrhosis in Italy. Collaborative Groups for the Study of Liver Diseases in Italy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Do certain countries produce only positive results? A systematic review of controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Meta-analysis of propylthiouracil for alcoholic liver disease--a Cochrane Hepato-Biliary Group Review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Controlled study of the therapeutic effect of B vitamins and an anabolic steroid in chronic hepatitis (author's transl)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Alcohol-induced hepatic injury in nonalcoholic volunteers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Meta-analyses of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

[Alcohol, liver cirrhosis and disorders in sex hormone metabolism]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Protein anabolism and fatty liver of the alcoholic

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Treatment of ascitic atrophic cirrhosis of the liver with high dosages of testosterone propionate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Anabolic-androgenic steroid treatment of liver diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Anabolic Steroid Effect on Hepatic Protein Synthesis in Patients with Liver Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Short-Term Parenteral and Peroral Testosterone Administration in Men with Alcoholic Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021

Hypothalamic–Pituitary–Gonadal Function in Relation to Liver Function in Men with Alcoholic Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003045

7 January 2021